Cevimeline Hydrochloride is being studied as a treatment for dry mouth caused by radiation therapy to the head and neck. It is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. Reference standards of Cevimeline Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Cevimeline Hydrochloride
Catalogue No.:PA 30 37000
CAS :
Molecular Formula : C10H18ClNOS
Molecular Weight : 235.77
Cevimeline N-Oxide
Catalogue No.:PA 30 37510
Molecular Formula : C10H17NO2S
Molecular Weight : 215.31
(1S,3R,4S)-3-((Tritylthio)methyl)quinuclidin-3-ol
Catalogue No.:PA 30 37520
Molecular Formula : C27H29NOS
Molecular Weight : 415.59
(1'S,2S,3'R,4'S)-2-Methyl-1'-azaspiro[[1,3]oxathiolane-5,3'-bicyclo[2.2.2]octan]-1'-ium Chloride
Catalogue No.:PA 30 37530
3-Hydroxy-1-azabicyclo[2.2.2]octane-3-methanol
Catalogue No.:PA 30 37540
Molecular Formula : C8H15NO2
Molecular Weight : 157.21
Cevimeline Sulfoxide
Catalogue No.:PA 30 37550
trans-Cevimeline Hydrochloride
Catalogue No.:PA 30 37560
3-Quinuclidinone Hydrochloride
Catalogue No.:PA 30 0371000
Molecular Formula : C7H12ClNO
Molecular Weight : 161.63
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
